| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |